Novartis Selects Denton Texas for Global Expansion of Advanced Radioligand Therapy Production
The pharmaceutical landscape is witnessing a significant shift toward precision medicine, and Novartis is positioning itself at the forefront of this evolution.
by 
Josh Weiner
Josh Weiner